8h
News-Medical.Net on MSNFlavonoids help regulate gut hormones and show promise in managing type 2 diabetesFlavonoids show promise in treating type 2 diabetes mellitus by targeting the enteroendocrine system and regulating key gut ...
Bio-Thera and Dr. Reddy's partner for biosimilar commercialization in Southeast Asia, expanding access to affordable ...
As it gears up to submit an approval application next year, Wave Life Sciences has presented fresh phase 2 data showing its ...
Wave Life Sciences announced positive data from the Phase 2 FORWARD-53 trial of WVE-N531, which is an exon skipping oligonucleotide being ...
12h
KSNT Topeka on MSNVenomous rattlesnakes slither out as temperatures warm in KansasKansans may need to watch their step when heading outside as snakes reappear across the state, and inside some unfortunate ...
WVE-N531, an oligonucleotide, elicited significant functional benefit and reversal of muscle damage in the Phase II ...
Wave Life Sciences (WVE) announced positive data from the Phase 2 FORWARD-53 trial of WVE-N531, which is an exon skipping oligonucleotide being ...
15h
Philstar.com on MSNP45 rice max SRP begins March 31 – DAA maximum suggested retail price of P45 per kilo of imported rice will be enforced starting March 31 amid declining global ...
Wave Life plans a 2026 NDA filing for WVE-N531 after positive Phase 2 data in Duchenne muscular dystrophy, showing functional gains and biomarker improvements.
Stephen Flynn - who was disabled for many years - slammed the UK Government's £5bn welfare cuts after the DWP's own assessment said they ...
For decades microtubule-targeting agents (MTAs) have been a cornerstone of cancer treatment regimens and continue to be heavily employed as backbone chemotherapy in combination with new targeted ...
Abdelghani M, et al . Experimental myositis: an optimised version of C-protein-induced myositis. RMD Open 2025;11:e004558. doi: 10.1136/rmdopen-2024–0 04 558 In this article, the abstract has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results